Integra Lifesciences Holdings Corp  

(Public, NASDAQ:IART)   Watch this stock  
Find more results for IART
61.49
0.00 (0.00%)
Jul 7 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 60.21 - 61.74
52 week 45.07 - 70.32
Open 61.32
Vol / Avg. 198,746.00/261,463.00
Mkt cap 2.03B
P/E 50.74
Div/yield     -
EPS 1.21
Shares 32.93M
Beta 0.76
Inst. own 83%
Aug 3, 2015
Q2 2015 Integra LifeSciences Holdings Corp Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jun 29, 2015
Integra LifeSciences Holdings Corp to Acquire TEI Biosciences and TEI Medical
Jun 2, 2015
Integra LifeSciences Holdings Corp at Jefferies Global Healthcare Conference
May 26, 2015
Integra LifeSciences Holdings Corp to Provide Historical Financials Adjusted for Discontinued Operations - Webcast
May 22, 2015
Integra LifeSciences Holdings Corp Annual Shareholders Meeting
May 20, 2015
Integra LifeSciences Holdings Corp Annual Shareholders Meeting (Estimated)
May 18, 2015
Integra LifeSciences Holdings Corp at UBS Global Healthcare Conference
May 14, 2015
Integra LifeSciences Holdings Corp at Bank of America Merrill Lynch Health Care Conference
May 6, 2015
Integra LifeSciences Holdings Corp at Deutsche Bank Health Care Conference
Apr 30, 2015
Q1 2015 Integra LifeSciences Holdings Corp Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 3.59% 3.66%
Operating margin 7.18% 7.06%
EBITD margin - 13.65%
Return on average assets 2.15% 2.45%
Return on average equity 4.83% 4.96%
Employees 3,400 -
CDP Score - -

Address

311 Enterprise Dr
PLAINSBORO, NJ 08536-3344
United States - Map
+1-609-2750500 (Phone)
+1-609-2755363 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Integra LifeSciences Holdings Corporation is a medical technology company. The Company offers solutions, such as orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. The Company's operating segments are: Specialty Surgical Solutions, and Orthopedics and Tissue Technologies. The Company's Specialty Surgical Solutions segment includes the Neurosurgery business and the Instruments business. The Company's Orthopedics and Tissue Technologies segment includes offerings, such as skin and wound repair, bone and joint fixation, implants in the upper and lower extremities, bone grafts, and nerve and tendon repair. The Company sources its handheld surgical instruments and specialty metal and pyrocarbon implants through third-party vendors. The Company manufactures its products in plants, which are located in the United States, Puerto Rico, France, Germany, Ireland and Mexico.

Officers and directors

Stuart M. Essig Chairman of the Board
Age: 53
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Peter J. Arduini President, Chief Executive Officer, Director
Age: 50
Bio & Compensation  - Reuters
Glenn G Coleman Chief Financial Officer, Corporate Vice President
Age: 47
Bio & Compensation  - Reuters
Padma Thiruvengadam Chief Human Resources Officer, Corporate Vice President - Strategic Initiatives and Operational Excellence
Age: 50
Bio & Compensation  - Reuters
Kenneth Burhop Ph.D. Chief Scientific Officer, Corporate Vice President
Age: 61
Bio & Compensation  - Reuters
John Mooradian Corporate Vice President - Global Operations and Supply Chain
Age: 59
Bio & Compensation  - Reuters
Richard D. Gorelick Corporate Vice President, General Counsel, Administration, Secretary
Age: 54
Bio & Compensation  - Reuters
Mark A. Augusti Corporate Vice President, President - Orthopedics and Tissue Technologies
Age: 49
Bio & Compensation  - Reuters
Robert T. Davis Jr. Corporate Vice President, President - Specialty Surgical Solutions
Age: 56
Bio & Compensation  - Reuters
Deborah Leonetti Corporate Vice President - Global Services and Repair
Age: 59
Bio & Compensation  - Reuters